ALPHA TRIBE

Parmax Pharma LtdImportant, 01-01-1970: Company Update

01-01-1970 | 12:00 am

To,

BSE Limited,

Phiroze Jeejeebhoy Towers,

Dalal Street, Fort, Mumbai - 400 001,

Maharashtra, India.

Sub: Submission of Public Announcement to the public shareholders of Parmax Pharma Limited

Scrip ID: PARMAX | Scrip Code: 540359

Ref: Open offer for acquisition of upto 23,46,250 (Twenty-Three Lakhs Forty-Six Thousand Two Hundred and

Fifty) fully paid-up equity shares of face value of ₹ 10.00 each (“Equity Shares”) of Parmax Pharma Limited

(the “Target Company”), representing 26.00% (Twenty-Six Percent) of the Expanded Voting Share Capital (as

defined below) of the Target Company from the Public Shareholders (as defined below) of the Target Company

by Dhiren Chandulal Shah (“Acquirer 1”) and Sunil Chinubhai Shah (“Acquirer 2”) hereinafter collectively

referred to as the (“Acquirers”) along with Dhairya Dhiren Shah (“PAC 1”), Hiren Pravin Doshi (“PAC 2”),

Sheetal Hiren Doshi (“PAC 3”), Nirmal Sunilbhai Shah (“PAC 4”), Rupa Sunil Shah (“PAC 5”), Vijaykumar

Natvarlal Shiyani (“PAC 6”), Kamlesh Natvarlal Shiyani (“PAC 7”), Abhay Chinubhai Shah (“PAC 8”), Umang

Alkesh Gosalia (“PAC 9”) and Meena Alkesh Gosalia (“PAC 10”) ( (PAC 1, PAC 2, PAC 3, PAC 4, PAC 4, PAC

5, PAC 6, PAC 7, PAC 8, PAC 9 and PAC 10, collectively referred to as the “PACs”), in their capacity as

persons acting in concert with the Acquirers for the purposes of the Open Offer (“Offer” or “Open Offer”)

Dear Sir/ Madam,

In relation to the captioned offer, we, Fedex Securities Private Limited, Manager to the proposed Open Offer herewith

enclose the Copy of Public Announcement, in compliance with Regulation 14(2) and 15 of Securities and Exchange

Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, as amended.

Kindly take the same on your record.

Thanking You,

Yours faithfully,

Yours faithfully,

For Fedex Securities Private Limited

Antara Chogle

Manager

Date: June 08, 2026

Place: Mumbai

Encl: Public Announcement

----------------Page (0) Break----------------

PUBLIC ANNOUNCEMENT UNDER REGULATION 3(1) AND REGULATION 4 READ WITH REGULATION 13, REGULATION 14 AND

REGULATION 15(1) OF THE SECURITIES AND EXCHANGE BOARD OF INDIA (SUBSTANTIAL ACQUISITION OF SHARES AND

TAKEOVERS) REGULATIONS, 2011 AND SUBSEQUENT AMENDMENTS THERETO

FOR THE ATTENTION OF THE PUBLIC SHAREHOLDERS OF PARMAX PHARMA LIMITED

Open offer for acquisition of upto 23,46,250 (Twenty-Three Lakhs Forty-Six Thousand Two Hundred and Fifty) fully paid-up equity shares of

face value of ₹ 10.00 each (“Equity Shares”) of Parmax Pharma Limited (the “Target Company”), representing 26.00% (Twenty-Six Percent) of

the Expanded Voting Share Capital (as defined below) of the Target Company from the Public Shareholders (as defined below) of the Target

Company by Dhiren Chandulal Shah (“Acquirer 1”) and Sunil Chinubhai Shah (“Acquirer 2”) hereinafter collectively referred to as the

(“Acquirers”) along with Dhairya Dhiren Shah (“PAC 1”), Hiren Pravin Doshi (“PAC 2”), Sheetal Hiren Doshi (“PAC 3”), Nirmal Sunilbhai Shah

(“PAC 4”), Rupa Sunil Shah (“PAC 5”), Vijaykumar Natvarlal Shiyani (“PAC 6”), Kamlesh Natvarlal Shiyani (“PAC 7”), Abhay Chinubhai Shah

(“PAC 8”), Umang Alkesh Gosalia (“PAC 9”) and Meena Alkesh Gosalia (“PAC 10”) ( (PAC 1, PAC 2, PAC 3, PAC 4, PAC 4, PAC 5, PAC 6,

PAC 7, PAC 8, PAC 9 and PAC 10, collectively referred to as the “PACs”), in their capacity as persons acting in concert with the Acquirers for

the purposes of the Open Offer (“Offer” or “Open Offer”), pursuant to and in compliance with the requirements of the Securities and Exchange

Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 and subsequent amendments thereto (“SEBI (SAST)

Regulations”).

This public announcement (“Public Announcement” or “PA”) is being issued by Fedex Securities Private Limited, the manager to the Offer (“Manager

to the Offer”), for and on behalf of the Acquirers and the PACs, to the Public Shareholders (as defined below) of the Target Company, with an intention

to acquire substantial number of equity shares, voting rights and control of the Target Company, pursuant to and in compliance with the provisions of

Regulations 3(1) and 4, read with Regulations 13, 14, 15(1) and other applicable regulations of the SEBI (SAST) Regulations.

DEFINITIONS:

For the purpose of this PA, the following terms would have the meaning assigned to them below:

a) “Equity Shares” shall mean the fully paid-up equity shares of face value of ₹ 10.00/- (Rupees Ten) each of the Target Company;

b) “Existing Share & Voting Capital” means paid-up share capital of the Target Company prior to Proposed Preferential Issue i.e., ₹ 3,74,13,000

divided into 37,41,300 equity shares of face value of ₹ 10.00 each;

c) “Expanded Voting Capital” shall mean the total voting equity share capital of the Target Company after taking into account all potential increases

in the voting equity share capital expected as of the 10th (tenth) working day from the closure of the tendering period for the Offer. This includes (i)

22,80,444 Acquirers Equity Shares (as defined below) proposed to be allotted by the Target Company to the Acquirers and PACs by way of

Preferential Issue (as defined below), subject to, inter alia, the approval of the shareholders of the Target Company and other statutory/ regulatory

approvals, if any; (ii) 8,57,142 Equity Shares proposed to be allotted by the Target Company to allottees under public category by way of preferential

issue, subject to, inter alia, the approval of the shareholders of the Target Company and other statutory/ regulatory approvals, if any; (iii) 17,16,574

Acquirers Warrants (as defined below), to be allotted by the Target Company to Acquirers and PAC 1 to PAC 8 by way of Preferential Issue (as

defined below), subject to, inter alia, the approval of the shareholders of the Target Company and other statutory/ regulatory approvals, if any, each

carrying a right to subscribe to 1 (one) Equity Share which may be exercised in one or more tranches during the period commencing from the date

of allotment until the expiry of 18 (eighteen) months from the date of allotment; and (iv) 4,28,571 Warrants, to be allotted by the Target Company

to allottees under public category by way of the preferential issue, subject to, inter alia, the approval of the shareholders of the Target Company and

----------------Page (1) Break----------------

other statutory/ regulatory approvals, if any, each carrying a right to subscribe to 1 (one) Equity Share which may be exercised in one or more

tranches during the period commencing from the date of allotment until the expiry of 18 (eighteen) months from the date of allotment;

d) “Proposed Preferential Issue” means the proposed preferential issue of (i) 31,37,586 Equity Shares, out of which 22,80,444 Equity Shares will be

issued to the Acquirers and the PACs at an issue price of ₹ 36.50/- per Equity Share and 8,57,142 Equity Shares will be issued to allottees under

public category at an issue price of ₹ 36.50/- per Equity Share, and (ii) 21,45,146 warrants convertible into equity shares (“Warrants”), out of which

17,16,574 warrants will be issued to the Acquirers and PAC 1 to PAC 8 at ₹ 36.50/- per warrant and 4,28,571 warrants to allottees under public

category at ₹ 36.50/- per warrant, as approved by Board of Directors of the Target Company at their Board Meeting held on Monday, June 08, 2026,

subject to approval of members and other statutory/ regulatory approvals.

e) “Parties to the Share Purchase Agreement” shall collectively mean Dhiren Chandulal Shah (“Acquirer 1”) and Sunil Chinubhai Shah (“Acquirer

2”), Dhairya Dhiren Shah (“PAC 1”), Hiren Pravin Doshi (“PAC 2”), Sheetal Hiren Doshi (“PAC 3”), Nirmal Sunilbhai Shah (“PAC 4”), Vijaykumar

Natvarlal Shiyani (“PAC 6”) and Kamlesh Natvarlal Shiyani (“PAC 7”) (collectively “SPA PACs”) and the Sellers;

f) “Existing Promoters” shall mean the promoters and members of the promoter group of the Target Company as on the date of this PA, in accordance

with the provisions of Regulations 2(1)(s) and 2(1)(t) of the SEBI (SAST) Regulations, read with Regulations 2(1)(oo) and 2(1)(pp) of the SEBI

(ICDR) Regulations;

g) “Sellers” shall mean (i) Alkesh Mahasukhlal Gopani (“Seller 1”), (ii) Vipul Mahasukhlal Gopani (“Seller 2”), and (iii) Pravina Mahasukh Gopani

(“Seller 3”) who have entered into a Share Purchase Agreement dated Monday, June 08, 2026, with the Acquirers and SPA PACs;

h) “Public Shareholders” means all the public shareholders of the Target Company who are eligible to tender their Equity Shares in the Offer, other

than: (i) the Existing Promoters; (ii) the Acquirers and the PACs, (iii) the Parties to Share Purchase Agreement, and (iii) any persons deemed to be

acting in concert with the persons set out in (i) and (ii), pursuant to and in compliance with the SEBI (SAST) Regulations;

i) “SEBI” means the Securities and Exchange Board of India;

j) “Tendering Period” shall have the meaning ascribed to it under the SEBI (SAST) Regulations; and

k) “Working Day” means any working day of the Securities Exchange Board of India (“SEBI”).

1. Offer Details

Offer Size

The Acquirers and the PACs hereby make this Open Offer to the Public Shareholders to acquire up to 23,46,250 (Twenty

Three Lakhs Forty-Six Thousand Two Hundred and Fifty) Equity Shares (“Offer Shares”), constituting 26.00% (twenty six

percent) of the Expanded Voting Capital, at a price of ₹ 42.80/- (Indian Rupees Forty-two and Eight Zero Paise only) per

Offer Share aggregating to a total consideration of up to ₹ 10,04,19,500.00/- (Indian Rupees Ten Crores Four Lakhs Nineteen

Thousand Five Hundred only) (assuming full acceptance) (“Offer Size”), subject to the receipt of the required statutory/

regulatory approval and the terms and conditions mentioned in this Public Announcement and to be set out in the detailed

public statement (“DPS”) and the letter of offer (“Letter of Offer” or “LOF”) that are proposed to be issued in relation to

the Open Offer in accordance with the SEBI (SAST) Regulations.

Offer Price /

Consideration

The Equity Shares of the Target Company are frequently traded in terms of the SEBI (SAST) Regulations. The Open Offer

is made at a price of ₹ 42.80/- (Indian Rupees Forty-two and Eight Zero Paise only) per Offer Share (“Offer Price”), which

has been determined in accordance with Regulations 8(2) of the SEBI (SAST) Regulations. Assuming full acceptance of the

----------------Page (2) Break----------------

Offer, the total consideration payable by the Acquirer in accordance with the SEBI (SAST) Regulations will be ₹

10,04,19,500.00/- (Indian Rupees Ten Crores Four Lakhs Nineteen Thousand Five Hundred only).

Mode of Payment

The Offer Price is payable in cash in accordance with the provision of Regulation 9(1)(a) of the SEBI (SAST) Regulations,

2011, and the terms and conditions mentioned in this PA and to be set out in the DPS, the Draft Letter of Offer (“DLOF”),

the Letter of Offer and any corrigendum thereto, if any, that are proposed to be issued in accordance with the SEBI (SAST)

Regulations.

Type of Offer

This Open Offer is a mandatory open offer made by the Acquirers and the PACs in compliance with Regulations 3(1) and 4

of the SEBI (SAST) Regulations, pursuant to substantial acquisition of shares, voting rights, and control over the Target

Company by the Acquirer, subject to receipt of the required regulatory approval. This Open Offer is not conditional upon any

minimum level of acceptance as per Regulation 19(1) of the SEBI (SAST) Regulations. This Open Offer is not a competing

offer in terms of Regulation 20 of the SEBI (SAST) Regulations.

2. Transaction which has triggered the open offer obligations (“Underlying Transaction”)

Details of Underlying Transaction

Type of

Transaction

(Direct/

Indirect)

Mode of Transaction (Agreement/

Proposed Allotment/ market purchase)

Shares / Voting rights acquired/

proposed to be acquired Total Consideration for

Equity Shares

/Voting rights

acquired

(in ₹)

Mode of

payment

(Cash/

securities)

Regulation

which has

triggered No. of Equity Shares

% vis a

vis total

equity /

voting

capital(1)

Direct

Share Purchase Agreement:

The Acquirers and SPA PACs have entered

into a Share Purchase Agreement dated

Monday, June 08, 2026 with the Sellers

(“SPA”), for acquisition of 11,52,450 (Eleven

Lakhs Fifty-two Thousand Four Hundred and

Fifty) Equity Shares at a price of ₹ 35.00/-

(Indian Rupees Thirty-Five only) per Equity

Shares, subject to and in accordance with the

terms and conditions contained in the SPA.

Acquirers – 5,38,315

Equity Shares

SPA PACs –

6,14,135 Equity

Shares

5.97%

6.81%

4,03,35,750.00/-

(Rupees Four

Crores Three

Lakhs Thirty-

Five Thousand

Seven Hundred

and Fifty Only) Cash

Regulation

3(1) and 4

of SEBI

(SAST)

Regulations,

2011

Direct

Preferential Issue of Equity Shares and

Warrants:

The board of directors of the Target Company

passed a resolution on Monday, June 08, 2026

authorizing the issuance and allotment of the

following securities of the Target Company to

----------------Page (3) Break----------------

the Acquirers and PACs, by way of a

preferential issue on a private placement basis,

in the following manner (“Preferential

Issue”) (2):

a) 22,80,444 (Twenty-Two Lakhs Eighty

Thousand Four Hundred and Forty-Four)

Equity Shares (“Acquirers Equity

Shares”) at a price of ₹ 36.50/- (Indian

Rupees Thirty-Six and Five Zero Paise

only) per Equity Share to the Acquirers

and PACs by way of a preferential

allotment, for an aggregate consideration

of ₹ 8,32,36,206.00/- (Indian Rupees

Eight Crores Thirty-Two Lakhs Thirty-

Six Thousand Two Hundred and Six

only). The Preferential Issue is under

section 62 of the Companies Act, 2013

and in terms of SEBI (ICDR) Regulations

2018 and subject to statutory/ regulatory

approvals.

b) 17,16,574 (Seventeen Lakhs Sixteen

Thousand Five Hundred Seventy-Four)

warrants convertible into equity shares

(“Acquirers Warrants”) at a price of ₹

36.50/- (Indian Rupees Thirty-Six and

Five Zero Paise only) per warrant to the

Acquirers and PAC 1 to PAC 8 by way of

a preferential allotment, for an aggregate

consideration of ₹ 6,26,54,951.00/-

(Indian Rupees Six Crores Twenty-Six

Lakhs Fifty-Four Thousand Nine Hundred

Fifty-One only). The Preferential Issue is

under section 62 of the Companies Act,

2013 and in terms of SEBI (ICDR)

Regulations 2018 and subject to statutory/

regulatory approvals.

Acquirers – 6,96,101

Equity Shares

PAC 1 to 9 –

15,84,343 Equity

Shares

Acquirers – 6,17,209

Equity Shares

PAC 1 to PAC 8 –

10,99,365 Equity

Shares

7.71%

17.56%

6.84%

12.18%

₹ 8,32,36,206/-

(Indian Rupees

Eight Crores

Thirty-Two

Lakhs Thirty-Six

Thousand Two

Hundred and Six

only)

₹ 6,26,54,951/-

(Indian Rupees

Six Crores

Twenty-Six

Lakhs Fifty-Four

Thousand Nine

Hundred Fifty-

One only)

Total (4) 57.06% 51,49,468

----------------Page (4) Break----------------

Notes:

1. Calculated as a percentage of the Expanded Voting Capital.

2. The Acquirers Equity Shares and Acquirers Warrants shall be allotted within the timelines prescribed under regulation 170 of the Securities and Exchange Board of India (Issue of Capital and Disclosure

Requirements) Regulations, 2018, subject to, inter alia, the approval of the shareholders of the Target Company and other statutory approvals, if any.

3. Upon completion of the Underlying Transaction, the Sellers / Existing Promoters shall cease to hold any Equity Shares in the Target Company. The Existing Promoters shall relinquish the control and

management of the Target Company in favour of the Acquirers and PACs and accordingly, be declassified from the promoter and promoter group category in accordance with the provisions of Regulation

31A of the SEBI (LODR) Regulations, 2015.

4. In terms of regulation 38 of SEBI (LODR) Regulations, 2015 read with Rule 19(2) and 19A of the Securities Contract (Regulation) Rules, 1957, (the “SCRR”), as amended from time to time, the Target

Company is required to maintain at least 25% public shareholding on a continuous basis for listing. If as a result of acquisition of Equity Shares pursuant to the Underlying Transaction and/or the Open

Offer, the public shareholding in the Target Company falls below the minimum public shareholding requirement as per SCRR and the SEBI (LODR) Regulations, then the Acquirers and PACs have agreed

to take necessary steps to ensure compliance with the minimum public shareholding requirements in the manner and timelines prescribed under applicable law..

Pursuant to the consummation of the Underlying Transaction and subject to compliance with the SEBI (SAST) Regulations, 2011, the Acquirers and

PACs will acquire control over the Target Company and will be identified as promoters and members of the promoter group of the Target Company,

including in accordance with the provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations,

2015 (“SEBI (LODR) Regulations, 2015”). The Acquirers and the PACs does not intend to delist the Target Company pursuant to this open offer in

accordance with the SEBI (SAST) Regulations and the Securities and Exchange Board of India (Delisting of Equity Shares) Regulations, 2021.

3. Acquirers / PACs

Details Acquirer 1 Acquirer 2 PAC 1 PAC 2 PAC 3 PAC 4 PAC 5 PAC 6 PAC 7 PAC 8 PAC 9 PAC 10

Name of Acquirer(s) /

PAC(s)

Dhiren

Chandulal

Shah

Sunil

Chinubhai

Shah

Dhairya

Dhiren

Shah

Hiren

Pravin

Doshi

Sheetal

Hiren

Doshi

Nirmal

Sunilbhai

Shah

Rupa

Sunil Shah

Vijaykum

ar

Natvarlal

Shiyani

Kamlesh

Natvarlal

Shiyani

Abhay

Chinubhai

Shah

Umang

Alkesh

Gosalia

Meena

Alkesh

Gosalia

Address

1101, 11th

Floor, The

Art House,

V.M.

Road, 20

Swastik

Society,

J.V.P.D.

Scheme,

VTC, Vile

Parle –

West,

Mumbai

400056

31

Vidyabhav

an, 22/39

New

Jagnath

Plot, Dr.

Yagnik

Road,

Rajkot,

Gujarat,

360001

Plot No.

20, 12th

Floor, The

Art House,

V.L.

Mehta

Road,

Swastik

Society,

J.V.P.D.

Scheme,

VTC, Vile

Parle

West,

Mumbai

400056

206/C,

Dharam

Palace,

2nd Floor,

Hughes

Road,

Near Sukh

Sagar,

Gamdevi,

Grant

Road,

Mumbai,

400007

206/C,

Dharam

Palace,

2nd Floor,

Hughes

Road,

Near Sukh

Sagar,

Gamdevi,

Grant

Road,

Mumbai,

400007

31

Vidyabhav

an, 22/39

New

Jagnath

Plot, Dr.

Yagnik

Road,

Rajkot,

Gujarat,

360001

31

Vidyabhav

an, 22/39

New

Jagnath

Plot, Dr.

Yagnik

Road,

Rajkot,

Gujarat,

360001

3- Sardar

Nagar Co.

Op.

Society,

Mavdi

Road,

Rajkot,

Mavdi,

Gujarat,

360004

3- Sardar

Nagar

Society,

Mavdi

Road, Nr

Patel

Boarding

Rajkot,

Mavdi,

Gujarat,

360004

C-5

Snehadri

Apartment

, Shreyas

Tekra,

Ambawadi

,

Ahmadaba

d City,

Ahmedaba

d, Gujarat,

380015

A-1102

Bilipatra

Apartment

B/H Balaji

Hall

Off. 150 ft

Ring Road

Near K.G

Dholakiya

School

Rajkot,

Gujarat -

360004

A-1102

Bilipatra

Apartment

B/H Balaji

Hall

Off. 150 ft

Ring Road

Near K.G

Dholakiya

School

Rajkot,

Gujarat -

360004

Name(s) of persons in

control/ promoters of

Acquirer(s)/ PAC(s)

where Acquirer/

PAC(s) are companies

Not

Applicable

Not

Applicable

Not

Applicable

Not

Applicable

Not

Applicable

Not

Applicable

Not

Applicable

Not

Applicable

Not

Applicable

Not

Applicable

Not

Applicable

Not

Applicable

Name of the group, if

any, to which the

Not

Applicable

Not

Applicable

Not

Applicable

Not

Applicable

Not

Applicable

Not

Applicable

Not

Applicable

Not

Applicable

Not

Applicable

Not

Applicable

Not

Applicable

Not

Applicable

----------------Page (5) Break----------------

Acquirer(s)/PAC(s)

belongs to

Pre-

transaction

shareholdin

g (A)

No. of

shares Nil Nil Nil Nil Nil 32,500(2) Nil Nil 7,500(2) Nil 200,000 4,74,800

% of

total

Voting

Share

Capital

Not

Applicable

Not

Applicable

Not

Applicable

Not

Applicable

Not

Applicable 0.90%

Not

Applicable

Not

Applicable 0.21%

Not

Applicable 5.35% 12.69%

Equity

Shares

proposed to

be acquired

through

Share

Purchase

Agreement

transaction

(B)

No. of

shares 4,67,238 71,077 93,448 1,68,206 18,690 92,097 Nil 1,24,597 1,17,097 Nil Nil Nil

% of

total

Voting

Share

Capital

(3)

5.18% 0.79% 1.04% 1.86% 0.21% 1.02% Not Applicable 1.38% 1.30% Not Applicable Not Applicable Not Applicable

Equity

Shares

proposed to

be acquired

through

Preferential

Issue

(Acquirers

Equity

shares and

Acquirers

Warrants)

(C)

No. of

shares 11,39,905 1,73,405 2,27,981 4,10,365 45,596 3,09,547 1,30,569 3,03,974 3,05,260 6,07,950 3,42,466 Nil

% of

total

Expande

d Voting

Share

Capital

(3)

12.63% 1.92% 2.53% 4.55% 0.51% 3.43% 1.45% 3.37% 3.38% 6.74% 3.80% Not Applicable

Equity

Shares

proposed to

be acquired

through

Offer

transaction

assuming

full

acceptance

(D)

No. of

shares 11,73,125 11,73,125 Nil Nil Nil Nil Nil Nil Nil Nil Nil Nil

% of

total

Expande

d Voting

Share

Capital

(3)

13.00% 13.00% Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable Not Applicable

Proposed

shareholdin

g after

acquisition

of shares

which

triggered

the Offer

No. of

shares 27,80,268 14,17,607 3,21,429 5,78,571 64,286 4,34,144 1,30,569 4,28,571 4,29,857 6,07,950 5,42,466 4,74,800

% of

total

Expande

d Voting

Share

Capital

(3)

30.81% 15.71% 3.56% 6.41% 0.71% 4.81% 1.45% 4.75% 4.76% 6.74% 6.01% 5.26%

----------------Page (6) Break----------------

(A+B+C+D)

(1)

Any other interest in the

Target Company None None None None None None None None None None

Managing

Director

of the

Target

Company

Mother of

Umang

Gosalia,

Managing

Director of

the Target

Company

Notes:

1) Assuming full acceptance of the Open Offer.

2) The pre-transaction shareholding of the PAC 4 and PAC 7 includes shares acquired from public shareholders pursuant to the Share Purchase Agreement (“SPA”) dated April 13, 2026, executed prior to

the Underlying Transaction; accordingly, such shares form part of the PACs' pre-transaction shareholding disclosed herein.

3) Including 31,37,586 Equity Shares to be issued by the Target Company to Acquirers, PAC 1 to 9 and allottees under public category and 21,45,145 Equity Shares to be issued by the Target Company to

Acquirers, PAC 1 to PAC 8 and allottees under public category on exercise of 21,45,145 Warrants (assuming exercise of all of the Warrants), through the Proposed Preferential Issue. The number of Equity

Shares to be acquired by each of the Acquirers under the Open Offer will be decided by the Acquirers basis the response received from the Public Shareholders under the Open Offer.

4) As per Regulation 38 of the SEBI (LODR) Regulations, 2015 read with Rule 19A of the Securities Contract (Regulation) Rules, 1957, as amended (“SCRR”), the Target Company is required to maintain

minimum public shareholding, as determined in accordance with the SCRR, on a continuous basis for listing. Upon completion of the Open Offer and the Underlying Transaction, if the public shareholding

of the Target Company falls below the minimum level of public shareholding as required to be maintained by the Target Company as per the SCRR and the SEBI (LODR) Regulations, 2015, the Acquirers

undertake to take necessary steps as required under applicable law to bring down the non-public shareholding to 75.00% (seventy five percent) through such routes and within such timelines as may be

permitted under law or approved by SEBI from time to time.

4. Details of Sellers (i.e., selling shareholders under the SPA)

The Acquirers and SPA PACs have entered into the Share Purchase Agreement (“SPA”) with the Sellers, on Monday, June 08, 2026, for acquisition

of the Sale Shares (i.e. 11,52,450 (Eleven Lakhs Fifty-Two Thousand Four Hundred and Fifty Only) fully paid-up Equity Shares of ₹ 10.00/- each

representing 12.77% of the Expanded Voting Capital of the Target Company) at a price of ₹ 35.00/- (Indian Rupees Thirty-Five only) per Equity Share

aggregating to ₹ 4,03,35,750.00/- (Indian Rupees Four Crores Three Lakhs Thirty-Five Seven Hundred and Fifty Only), subject to the terms and the

conditions as mentioned in the SPA. The Details of the Selling Shareholders are as stated hereunder:

Name of the Selling

Shareholders

Part of promoter

group (Yes/ No)

Details of Equity Shares / Voting Rights held by the Selling Shareholders

Pre-Transaction Post-Transaction

No. of Equity

Shares %*

No. of Equity

Shares %*

Alkesh Mahasukhlal

Gopani (Seller 1) Yes 6,70,380 7.43% Nil N.A.

Vipul Mahasukhlal

Gopani (Seller 2) Yes 4,81,370 5.33% Nil N.A.

Pravina Mahasukh

Gopani (Seller 3) Yes 700 0.01% Nil N.A.

Total 11,52,450 12.77%

*The percentage have been calculated on the basis of Expanded Voting Capital of the Target Company.

----------------Page (7) Break----------------

Notes:

(1) Upon completion of the Underlying Transaction, the Sellers / Existing Promoters shall cease to hold any Equity Shares in the Target Company. The Existing Promoters shall relinquish the control and

management of the Target Company in favour of the Acquirers and PACs and accordingly, be declassified from the promoter and promoter group category in accordance with the provisions of Regulation 31A

of the SEBI (LODR) Regulations, 2015.

(2) The Sellers have not been prohibited by SEBI, from dealing in securities, in terms of directions issued by SEBI under Section 11B of the SEBI Act or any other regulations made under the SEBI Act.

5. Target Company

Name of the Target Company Parmax Pharma Limited

Company Identification Number (“CIN”) L24231GJ1994PLC023504

Exchanges where Listed BSE Limited

Registered Office Address, Tel. No, Email

id, Website

Plot No. 20, Survey No. 52, Rajkot-Gondal National Highway No. 27, Hadamtala, Tal. Kotda Sangani,

Rajkot, Gujarat, 360311.

Tel. no.: +91 2827 270534

Email ID: cs@parmaxpharma.com

Website: www.parmaxpharma.com

Exchange where listed Equity Shares are listed on the BSE Limited (“BSE”)

Scrip Code for BSE Limited 540359

Scrip ID for BSE Limited PARMAX

ISIN INE240T01014

6. Other Details

6.1. This PA is made in compliance with the provisions of Regulation 13 of the SEBI (SAST) Regulations.

6.2. The DPS to be issued under the SEBI (SAST) Regulations shall be published in newspapers, within 5 (five) Working Days of this PA, in accordance

with Regulations 13(4), 14(3) and 15(2) of the SEBI (SAST) Regulations, i.e., on or before Monday, June 15, 2026. The DPS, shall, inter alia, contain

details of the Open Offer including detailed information on the Offer Price, the Acquirers, PACs, the Sellers, the Target Company, the background

to the Open Offer, statutory approvals required, details of financial arrangements and such other terms and conditions as applicable to this Offer. The

DPS will be published, as required by Regulation 14(3) of the SEBI (SAST) Regulations, in all editions of any one English national daily newspaper

with wide circulation, any one Hindi national daily newspaper with wide circulation, any one regional language daily newspaper with wide circulation

at the place where the registered office of the Target Company is situated i.e., Rajkot, and any one regional language daily newspaper at the place of

the stock exchange where the maximum volume of trading in the Equity Shares was recorded during the 60 (sixty) trading days preceding the date

of this Public Announcement i.e. Mumbai.

6.3. The Offer is not conditional upon any minimum level of acceptance in terms of Regulation 19(1) of the SEBI (SAST) Regulations.

6.4. This PA is not being issued pursuant to a competing offer in terms of Regulation 20 of the SEBI (SAST) Regulations.

6.5. The Acquirers and PACs have no intention to delist the Equity Shares of the Target Company pursuant to this Open Offer in accordance with the

SEBI (SAST) Regulations and the SEBI (Delisting of Equity Shares) Regulations, 2021.

6.6. The Acquirers and PACs undertake that they are aware of and will comply with their obligations as laid down in the SEBI (SAST) Regulations. The

Acquirers confirm that they have adequate financial resources to meet the obligations under the SEBI (SAST) Regulations for the purposes of the

Offer and have made firm financial arrangements for financing the acquisition of the Offer Shares, in terms of Regulation 25(1) of the SEBI (SAST)

----------------Page (8) Break----------------

Regulations.

6.7. The Underlying Transaction is subject to the satisfaction of certain conditions precedent and the SPA not being terminated prior to Closing. This

Open Offer is also subject to the other terms and conditions mentioned in this PA, and as will be set out in the DPS, the DLOF, and the Letter of

Offer that are proposed to be issued in accordance with the SEBI (SAST) Regulations.

6.8. The information pertaining to Target Company and/or Sellers contained in this PA has been compiled from the information published or publicly

available sources and/ or provided by the Target Company or the Sellers, as the case may be. Accordingly, the accuracy of such information has not

been independently verified by any of the Acquirers, PACs and/or the Manager to the Offer and none of the Acquirers, nor the PACs nor the Manager

to the Offer accept any responsibility with respect to such information relating to the Target Company and/or the Seller.

6.9. In this PA, all references to “Rs.” or “₹” or “INR” are references to Indian Rupees and any discrepancy in figures as a result of multiplication or

totalling is due to rounding off.

Issued by the Manager to the Offer on behalf of the Acquirers and PACs:

FEDEX SECURITIES PRIVATE LIMITED

B7, Jay Chambers, Dayaldas Road, Vile Parle East, Mumbai – 400057, Maharashtra, India

Tel. No.: +91 81049 85249

Email: mb@fedsec.in

Website: www.fedsec.in

Contact Person: Antara Chogle / Saipan Sanghvi

SEBI Registration Number: INM000010163

Signed by Acquirers and PACs:

Sd/-

Dhiren Chandulal Shah

(“Acquirer 1”)

Sd/-

Sunil Chinubhai Shah

(“Acquirer 2”)

Sd/-

Dhairya Dhiren Shah

(“PAC 1”)

Sd/-

Hiren Pravin Doshi

(“PAC 2”)

Sd/-

Sheetal Hiren Doshi

(“PAC 3”)

Sd/-

Nirmal Sunil Shah

(“PAC 4”)

Sd/-

Rupa Sunil Shah

(“PAC 5”)

Sd/-

Vijaykumar Natvarlal

Shiyani

(“PAC 6”)

Sd/-

Kamlesh Natvarlal

Shiyani

(“PAC 7”)

Sd/-

Abhay Chinubhai Shah

(“PAC 8”)

Sd/-

Umang Alkesh Gosalia

(“PAC 9”)

Sd/-

Meena Alkesh Gosalia

(“PAC 10”)

Place: Mumbai

Date: June 08, 2026

----------------Page (9) Break----------------

No comments yet. Be the first to comment!

All announcements from Parmax Pharma Ltd